Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Regulatory News (PRM)

Share Price Information for Proteome (PRM)

Share Price is delayed by 15 minutes
Get Live Data
1.50    -0.01 (-0.66%)
Bid:
1.50
Ask:
1.88
Spread: 0.38 (25.333%)
Market Cap: £5.26m
PRM Live PriceLast checked at - London Stock Exchange

Intraday Proteome Share Chart

Directorate Change

30 Sep 2014 07:00

RNS Number : 9286S
Proteome Sciences PLC
30 September 2014
 



 

 

 

 

 

Proteome Sciences plc

("Proteome Sciences" or the "Company")

Appointment of new Finance Director

 

30th September, 2014 - The Board of Proteome Sciences is pleased to announce the appointment of Mr. Geoffrey Ellis as Finance Director with effect from 1st October. Mr. Geoffrey John Ellis, 53, is a chartered accountant with over 30 years' experience in a range of senior financial, operational, sales and business development roles. He spent 15 years at Walt Disney where he was Chief Financial Officer of the Network of Disney Channels in EMEA and Managing Director of Disney Chanel Scandinavia, Middle East and Emerging Markets.

In addition to a strong financial background, he brings considerable international sales, marketing and licensing expertise and a key part of his role will be managing and expanding our commercial sales and marketing in USA and Europe.

Mr. James Malthouse will remain as a director of the company until his retirement on 30th November, 2014.

Mr. Ellis was a director of Curzon ISC Limited until shortly before it was placed into voluntary liquidation in March 2011. He was also a director of Warren Close Residents Association (Esher) Limited at the time it was placed into voluntary liquidation in May 2013.

Other than disclosed above, the Company confirms that there is no further information required to be disclosed in accordance with paragraph (g) of Schedule 2 of the AIM Rules.

 

- Ends -

For further information please contact:

Proteome Sciences plc

Christopher Pearce, Executive Chairman

Dr. Ian Pike, Chief Operating Officer Tel: +44 (0)1932 865065

James Malthouse, Finance Director

 

Cenkos - Nominated Adviser

Stephen Keys/Mark Connelly /Callum Davidson Tel: +44 (0)20 7397 8900

 

finnCap - Joint Broker

Geoff Nash (Corporate Finance) Tel: +44 (0)20 7220 0500

Tony Quirke (Broking)

 

IKON Associates - Public Relations

Adrian Shaw Tel: +44 (0)1483 271291

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAVKLFLZKFFBBX
Date   Source Headline
28th Jun 20064:32 pmPRNRe Licence Agreement
23rd May 20063:08 pmPRNRe Licence Agreement
26th Apr 20062:52 pmPRNBlocklisting
20th Apr 20064:39 pmPRNHolding(s) in Company
20th Apr 20064:36 pmPRNHolding(s) in Company
7th Apr 20065:20 pmRNSNotifiable Interest
22nd Mar 20064:00 pmPRNNotifiable Interest
22nd Feb 20062:30 pmRNSNotifiable Interest
13th Feb 20065:21 pmRNSNotifiable Interest Corrected
13th Feb 20065:18 pmRNSNotifiable Interest
10th Feb 20064:26 pmRNSNotifiable Interest
9th Feb 20068:30 amRNSNotifiable Interest
24th Jan 20064:32 pmRNSNotifiable Interest
25th Oct 20059:51 amPRNBlocklisting
26th Sep 200510:37 amPRNNotice of Results
5th Sep 20051:55 pmPRNHolding(s) in Company
23rd Jun 200511:18 amPRNHolding(s) in Company
20th Jun 200512:39 pmPRNHolding(s) in Company
16th Jun 20053:18 pmPRNHolding(s) in Company
7th Jun 20058:43 amPRNStatement re Grant of Options
3rd Jun 20053:32 pmPRNCorrection : Final Results
3rd Jun 20057:04 amPRNFinal Results
13th May 20051:37 pmPRNHolding(s) in Company
25th Apr 20059:48 amPRNBlocklisting
11th Apr 200510:29 amPRNHolding(s) in Company
8th Apr 20059:29 amPRNHolding(s) in Company
7th Apr 20058:13 amPRNCorrection : Holding(s) in Company
7th Apr 20057:18 amPRNHolding(s) in Company
1st Apr 20053:41 pmPRNDirector Shareholding
1st Apr 20056:00 amPRNRe Contract
1st Apr 20056:00 amPRNTrading Update & Placing
16th Mar 200510:41 amPRNHolding(s) in Company
2nd Feb 20059:24 amPRNHolding(s) in Company
6th Jan 200510:59 amRNSChange of Adviser
5th Jan 20054:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.